Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy
Author(s) -
Elia Lo Priore,
David M. Livermore,
Niccolò Buetti,
Philipp Jent,
Niklas Pelzer,
Carlo Casanova,
Hansjakob Furrer,
Baharak Babouee Flury
Publication year - 2020
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofz551
Subject(s) - tigecycline , medicine , prostatitis , multiple drug resistance , escherichia coli , microbiology and biotechnology , antibiotics , prostate , biology , biochemistry , cancer , gene
We present a successful treatment, with tigecycline monotherapy, of acute prostatitis caused by multidrug-resistant Escherichia coli harboring an NDM-1 carbapemenase along with a CMY-2 cephalosporinase and a TEM ESBL.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom